Evolving Market Trends In The Opioids Industry: Innovative Drug Solutions Transforming The Opioid Market Landscape

The Opioids Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Opioids Market Size During the Forecast Period?
There has been a consistent expansion in the opioids market size over the past few years. It is projected that this market will increase from $23.54 billion in 2024 to $24.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.9%. The historical growth has been driven by factors such as pain management, surgical procedures, palliative care, and the regulatory environment.

The market size of opioids is projected to experience consistent expansion over the coming years. It's predicted that its value will reach $27.62 billion by 2029, growing at a compound annual growth rate (CAGR) of 3.3%. The growth during the predicted period can be linked to non-cancer pain signals, regulatory shifts, telemedicine, and remote prescribing, as well as chronic pain management. Key trends during this projected timeframe include strategies to reduce opioid usage, medication-assisted treatment (MAT), risk reduction, and public health programs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13021

What Are the High-Growth Segments in the Opioids Market?
The opioids market covered in this report is segmented -

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types
2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist
3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain
4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies
5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:
1) By Methadone: Methadone Tablets, Methadone Oral Solution
2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations
3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets
4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations
5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules
6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations
7) By Other Product Types: Buprenorphine, , Other Combination Products

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Key Drivers Are Expected to Influence Future Opioids Market Growth?
The growth of the opioids market is anticipated to be fueled by the surge in surgical procedures. These procedures, which usually require anesthetic or breathing support and involve making an incision with tools, are defined as medical treatments typically carried out in an operating room. Opioids are oftentimes utilized in these procedures as part of pain management and anesthesia. For example, in August 2023, the France-based intergovernmental organization, Organization for Economic Co-operation and Development, reported an 8.4% rise in the total number of cataract surgical procedures performed in the Czech Republic, increasing from 131,612 procedures in 2021 to 142,670 in 2022. Additionally, the total number of inguinal hernia surgical procedures carried out in Turkey using laparoscopic repair increased by 35.2%, from 18,739 in 2021 to 25,348 in 2022. Consequently, the ascend in surgical procedures is expected to stimulate the opioids market. Another significant driving factor for the global opioids market is the growing prevalence of long-term or chronic diseases, also referred to as non-communicable diseases (NCDs). Chronic diseases are typically slow-progressing, persistent medical conditions that can last for several years or even for a lifetime and are usually not self-resolvable. With a higher number of individuals developing chronic diseases and suffering from enduring pain, the demand for opioids has seen an escalation. The application of opioids in managing chronic diseases is an intricate and developing segment in medicine, known for effectively alleviating pain. For instance, the World Health Organization, a Switzerland-based agency affiliated with the United Nations, reported in September 2022 that out of the 41 million yearly global deaths from non-communicable diseases (NCDs) or chronic diseases, (which accounted for 74% of all deaths), 17.9 million were due to cardiovascular diseases, 9.3 million were due to cancer, 4.1 million were due to chronic respiratory diseases and diabetes accounted for 2.0 million deaths. Thus, the rise in chronic diseases is catalyzing the growth of the opioids market.

Which Companies Hold the Largest Share Across Different Opioids Market Segments?
Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

What Trends Are Driving Growth in The Opioids Market?
Leading businesses functioning in the opioid market are concentrating on developing progressive drug treatments to strengthen their standing in the sector. The introduction of novel medicines has the potential to not only cure diseases but also enhance healthcare and scientific comprehension. In May 2023, for instance, Braeburn Pharmaceuticals Inc., a US company offering solutions to deal with opioid addiction, reported that Brixadi (buprenorphine), its newest extended-release injectable for subcutaneous use (under the skin), was approved by the US Food and Drug Administration for managing mild to severe opioid use disorder (OUD). It holds the distinction of being the only weekly and monthly subcutaneous injection for mild to severe OUD, and the first buprenorphine injectable using FluidCrystal Injection Depot Technology. If prescriptions are adhered to, patients receiving oral buprenorphine-based drugs can switch to equivalent doses.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

What Are the Emerging Geographies for The Opioids Market Growth?
North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Opioids Market?
2. What is the CAGR expected in the Opioids Market?
3. What Are the Key Innovations Transforming the Opioids Industry?
4. Which Region Is Leading the Opioids Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.